dipyridamole has been researched along with Arrhythmias, Cardiac in 40 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
Excerpt | Relevance | Reference |
---|---|---|
"These results indicate that administration of dipyridamole can prevent and terminate reperfusion arrhythmias such as AIVR and VT." | 9.09 | Antiarrhythmic efficacy of dipyridamole in treatment of reperfusion arrhythmias : evidence for cAMP-mediated triggered activity as a mechanism responsible for reperfusion arrhythmias. ( Akahoshi, M; Hirai, M; Hirayama, H; Inden, Y; Ito, T; Kondo, T; Murakami, Y; Okamoto, M; Saito, H; Toyama, J; Tsuboi, N; Tsuda, M; Tsuji, Y; Yamada, T; Yoshida, Y, 2000) |
" Therefore, we sought to evaluate whether dipyridamole-induced myocardial ischemia, as directly detected by echocardiographic monitoring of regional contractile function, would affect QT dispersion." | 7.72 | Effects of acute myocardial ischemia on QT dispersion by dipyridamole stress echocardiography. ( Ambrosio, G; Bentivoglio, M; Biagioli, P; Carluccio, E; Locati, EH; Mariotti, M; Politano, M; Sardone, M; Savino, K, 2003) |
"In a population of patients with chronic renal failure (CRF) and a high prevalence of left ventricular hypertrophy (LVH) undergoing chronic hemodialysis, we investigated the association between the results of dipyridamole-thallium tests (DTTs) and the occurrence of ventricular arrhythmias." | 7.68 | Dipyridamole-thallium tests are predictive of severe cardiac arrhythmias in patients with left ventricular hypertrophy. ( Barbieri, A; Canziani, ME; Cassiolato, JL; Castiglioni, ML; Draibe, SA; Gil, MA; Lima, VC; Martinez, EE; Saragoça, MA, 1991) |
"To examine the incidence of arrhythmias in dipyridamole infusion and the relation between dipyridamole-induced arrhythmias and ST-segment depression, dipyridamole electrocardiography tests were performed on 100 patients with coronary artery disease." | 7.68 | Relation between the incidence of arrhythmias and ischemic ST-segment depression during dipyridamole electrocardiography test in patients with coronary artery disease. ( Hanashima, K; Ikeda, K; Kubota, I; Shibata, T; Tsuiki, K; Yamaki, M; Yasui, S, 1991) |
"A case of dysgeusia during treatment with dipyridamole for congestive heart failure is reported." | 5.27 | Dysgeusia after high dose dipyridamole treatment (short communication). ( Finci, L; Goy, JJ; Sigwart, U, 1985) |
"These results indicate that administration of dipyridamole can prevent and terminate reperfusion arrhythmias such as AIVR and VT." | 5.09 | Antiarrhythmic efficacy of dipyridamole in treatment of reperfusion arrhythmias : evidence for cAMP-mediated triggered activity as a mechanism responsible for reperfusion arrhythmias. ( Akahoshi, M; Hirai, M; Hirayama, H; Inden, Y; Ito, T; Kondo, T; Murakami, Y; Okamoto, M; Saito, H; Toyama, J; Tsuboi, N; Tsuda, M; Tsuji, Y; Yamada, T; Yoshida, Y, 2000) |
"The risk of dangerous arrhythmia during either dobutamine SE or dipyridamole SE is small and similar in both groups." | 3.73 | [Prevalence of dangerous arrhythmia during pharmacological stress echocardiography]. ( Ciesielczyk, M; Drozdz, J; Kasprzak, JD; Krzemińska-Pakuła, M; Lipiec, P; Wejner-Mik, P, 2006) |
" Therefore, we sought to evaluate whether dipyridamole-induced myocardial ischemia, as directly detected by echocardiographic monitoring of regional contractile function, would affect QT dispersion." | 3.72 | Effects of acute myocardial ischemia on QT dispersion by dipyridamole stress echocardiography. ( Ambrosio, G; Bentivoglio, M; Biagioli, P; Carluccio, E; Locati, EH; Mariotti, M; Politano, M; Sardone, M; Savino, K, 2003) |
"To establish whether safety and feasibility of dobutamine and dipyridamole stress echocardiography are affected by history of hypertension." | 3.71 | Safety and feasibility of dobutamine and dipyridamole stress echocardiography in hypertensive patients. ( Bigi, R; Cortigiani, L; Desideri, A; Fiorentini, C; Nannini, E; Zanetti, L, 2002) |
"In a population of patients with chronic renal failure (CRF) and a high prevalence of left ventricular hypertrophy (LVH) undergoing chronic hemodialysis, we investigated the association between the results of dipyridamole-thallium tests (DTTs) and the occurrence of ventricular arrhythmias." | 3.68 | Dipyridamole-thallium tests are predictive of severe cardiac arrhythmias in patients with left ventricular hypertrophy. ( Barbieri, A; Canziani, ME; Cassiolato, JL; Castiglioni, ML; Draibe, SA; Gil, MA; Lima, VC; Martinez, EE; Saragoça, MA, 1991) |
"To examine the incidence of arrhythmias in dipyridamole infusion and the relation between dipyridamole-induced arrhythmias and ST-segment depression, dipyridamole electrocardiography tests were performed on 100 patients with coronary artery disease." | 3.68 | Relation between the incidence of arrhythmias and ischemic ST-segment depression during dipyridamole electrocardiography test in patients with coronary artery disease. ( Hanashima, K; Ikeda, K; Kubota, I; Shibata, T; Tsuiki, K; Yamaki, M; Yasui, S, 1991) |
"In order to examine the clinical usefulness of the vulnerability map, body surface mapping was performed in ten normal subjects and 32 patients with CAD using dipyridamole infusion to induce ventricular arrhythmias." | 3.67 | Using body surface mapping to detect vulnerability to ventricular arrhythmias in patients with coronary artery disease. ( Ikeda, K; Kubota, I; Tsuiki, K; Yasui, S; Yasumura, S, 1987) |
" In this study, twenty hours after coronary ligature, cardiac arrhythmia was reduced by oral administration of quinidine and phenytoin." | 3.67 | Use of experimental myocardial infarct to demonstrate arrhythmogenic activity of drugs. ( Duchene-Marullaz, P; Lavarenne, J; Trolese, JF; Trolese-Mongheal, Y, 1985) |
"On the basis of an examination of 412 patients with myocardial infarction the efficacy of a long-term employment (for 3--4 days) of a neuroleptic Droperidol and a vasodilator Curantyl was examined." | 3.65 | [Experience with combined use of neurolepsy and vasodilator substances in the treatment of patients with acute myocardial infarct]. ( Aleksandrova, LA; Avdiushko, BR; Gvatua, NA; Kravtsov, VL; Strokach, NT, 1976) |
"Dipyridamole pretreatment resulted in significant preservation of systolic and diastolic left ventricular performance during percutaneous transluminal coronary angioplasty, as documented by an unaffected global ejection fraction (vs." | 2.68 | Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance. ( Heidland, UE; Heintzen, MP; Schwartzkopff, B; Strauer, BE, 1996) |
"Dipyridamole/atropine test was carried out in 184, dobutamine/atropine test - in 231, transesophageal atrial pacing (TEAP) - in 154, veloergometry (VEM) in half sitting position - in 122, and combination stress-echoCG - in 668 patients (dipyridamole/TEAP, n=151; dipyridamole/dobutamine, n=162; dipyridamole/paired TAP, n=112)." | 1.35 | [Complications of stress-echocardiography used for diagnosis of ischemic heart disease]. ( Mikheev, NN, 2008) |
"Dyspnea was noted in 80 cases (40." | 1.27 | [How dangerous is the dipyridamole test?]. ( Bramann, HU; Görtz, P; Grosse-Heitmeyer, W; Mönninghoff, W; Most, E; St Müller, U, 1983) |
"Dipyridamole was infused intravenously at a rate of 0." | 1.27 | [Reverse redistribution in dipyridamole-loading thallium-201 images using single photon emission computed tomography]. ( Bunko, H; Masuda, M; Mori, K, 1986) |
"A case of dysgeusia during treatment with dipyridamole for congestive heart failure is reported." | 1.27 | Dysgeusia after high dose dipyridamole treatment (short communication). ( Finci, L; Goy, JJ; Sigwart, U, 1985) |
"Imipramine was infused at 1 mg/kg/min until cardiac failure and vascular collapse terminated the experiment at 21 +/- 2." | 1.27 | Treatment of haemodynamic and electrocardiographic side-effects resulting from imipramine toxicity in rats and dogs. ( Fiedler, VB; Göbel, H; Kettenbach, B; Nitz, RE, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (60.00) | 18.7374 |
1990's | 7 (17.50) | 18.2507 |
2000's | 8 (20.00) | 29.6817 |
2010's | 1 (2.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mathur, S | 1 |
Shah, AR | 1 |
Ahlberg, AW | 1 |
Katten, DM | 1 |
Heller, GV | 1 |
Cortigiani, L | 1 |
Zanetti, L | 1 |
Bigi, R | 1 |
Desideri, A | 1 |
Fiorentini, C | 1 |
Nannini, E | 1 |
Carluccio, E | 1 |
Biagioli, P | 1 |
Bentivoglio, M | 1 |
Mariotti, M | 1 |
Politano, M | 1 |
Savino, K | 1 |
Sardone, M | 1 |
Locati, EH | 1 |
Ambrosio, G | 1 |
DEMIROGLU, C | 1 |
BERKARDA, B | 1 |
OZTUERK, M | 1 |
GARAN, R | 1 |
HIKOSAKA, H | 1 |
FUJIWARA, M | 1 |
TODA, N | 1 |
Wejner-Mik, P | 1 |
Drozdz, J | 1 |
Lipiec, P | 1 |
Krzemińska-Pakuła, M | 1 |
Ciesielczyk, M | 1 |
Kasprzak, JD | 1 |
Chinnaiyan, KM | 1 |
Trivax, J | 1 |
Franklin, BA | 1 |
Williamson, B | 1 |
Kahn, JK | 1 |
Mikheev, NN | 1 |
Narasimhan, S | 1 |
Grosse-Heitmeyer, W | 1 |
Bramann, HU | 1 |
Görtz, P | 1 |
Mönninghoff, W | 1 |
St Müller, U | 1 |
Most, E | 1 |
Avellone, G | 1 |
Mandalà, V | 1 |
Novo, S | 1 |
Pinto, A | 1 |
Riolo, FP | 1 |
Davì, G | 1 |
Raneli, G | 1 |
Bayliss, J | 1 |
Pearson, M | 1 |
Sutton, GC | 1 |
De Vita, C | 1 |
Lazzeroni, E | 1 |
Picano, E | 2 |
Dodi, C | 1 |
Morozzi, L | 1 |
Chiriatti, GP | 1 |
Lu, C | 1 |
Botti, G | 2 |
Previtali, M | 1 |
Lanzarini, L | 1 |
Fetiveau, R | 1 |
Poli, A | 1 |
Ferrario, M | 1 |
Falcone, C | 1 |
Mussini, A | 1 |
Strauer, BE | 1 |
Heidland, UE | 1 |
Heintzen, MP | 1 |
Schwartzkopff, B | 1 |
Yoshida, Y | 1 |
Hirai, M | 1 |
Yamada, T | 1 |
Tsuji, Y | 1 |
Kondo, T | 1 |
Inden, Y | 1 |
Akahoshi, M | 1 |
Murakami, Y | 1 |
Tsuda, M | 1 |
Tsuboi, N | 1 |
Hirayama, H | 1 |
Okamoto, M | 1 |
Ito, T | 1 |
Saito, H | 1 |
Toyama, J | 1 |
Ortega, A | 1 |
Moreno, R | 1 |
Alonso, JC | 1 |
Domínguez, P | 1 |
Almoguera, I | 1 |
Bittini, A | 1 |
Martínez, L | 1 |
Moreno, M | 1 |
Sosa, V | 1 |
García Fernández, MA | 1 |
Pérez Vázquez, JM | 1 |
Haft, JI | 1 |
Tauchert, M | 1 |
Gvatua, NA | 1 |
Avdiushko, BR | 1 |
Aleksandrova, LA | 1 |
Strokach, NT | 1 |
Kravtsov, VL | 1 |
Modica, G | 1 |
Ferrante, R | 1 |
Arrigo, F | 1 |
Patané, S | 1 |
Quattrocchi, G | 1 |
Lucarini, AR | 1 |
Bongiorni, MG | 1 |
Lattanzi, F | 1 |
Marini, C | 1 |
Paperini, L | 1 |
L'Abbate, A | 1 |
Salvetti, A | 1 |
Saragoça, MA | 1 |
Canziani, ME | 1 |
Gil, MA | 1 |
Castiglioni, ML | 1 |
Cassiolato, JL | 1 |
Barbieri, A | 1 |
Lima, VC | 1 |
Draibe, SA | 1 |
Martinez, EE | 1 |
Shibata, T | 1 |
Kubota, I | 2 |
Ikeda, K | 2 |
Yamaki, M | 1 |
Hanashima, K | 1 |
Tsuiki, K | 2 |
Yasui, S | 2 |
Yasumura, S | 1 |
Eagle, KA | 1 |
Coley, CM | 1 |
Newell, JB | 1 |
Brewster, DC | 1 |
Darling, RC | 1 |
Strauss, HW | 1 |
Guiney, TE | 1 |
Boucher, CA | 1 |
Mori, K | 1 |
Masuda, M | 1 |
Bunko, H | 1 |
Michalík, D | 1 |
Simícek, J | 1 |
Jouve, R | 1 |
Larrue, J | 1 |
Cutler, BS | 1 |
Trolese-Mongheal, Y | 1 |
Trolese, JF | 1 |
Lavarenne, J | 1 |
Duchene-Marullaz, P | 1 |
Goy, JJ | 1 |
Finci, L | 1 |
Sigwart, U | 1 |
Fiedler, VB | 1 |
Kettenbach, B | 1 |
Göbel, H | 1 |
Nitz, RE | 1 |
Bassenge, E | 1 |
Doutheil, U | 1 |
Sano, N | 1 |
Sato, S | 1 |
Hashimoto, K | 1 |
Grisk, A | 1 |
Stremmel, D | 1 |
Visioli, O | 1 |
Ambanelli, U | 1 |
Stafford, A | 1 |
2 reviews available for dipyridamole and Arrhythmias, Cardiac
Article | Year |
---|---|
[Platelet anti-aggregant drugs and ischemic cardiopathy: evaluation of the effect on platelet aggregation and on antithrombin III].
Topics: Adult; Anticoagulants; Antithrombin III; Arrhythmias, Cardiac; Clofibrate; Dipyridamole; Female; Hum | 1981 |
Role of blood platelets in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Clofibrate; Co | 1979 |
4 trials available for dipyridamole and Arrhythmias, Cardiac
Article | Year |
---|---|
Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance.
Topics: Aged; Angioplasty, Balloon, Coronary; Arrhythmias, Cardiac; Aspirin; Coronary Vessels; Dipyridamole; | 1996 |
Antiarrhythmic efficacy of dipyridamole in treatment of reperfusion arrhythmias : evidence for cAMP-mediated triggered activity as a mechanism responsible for reperfusion arrhythmias.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Arrhythmias, Cardiac; Cyc | 2000 |
Role of blood platelets in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Clofibrate; Co | 1979 |
[Eicosanoids, myocardial ischemia and sudden death].
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Coronary Disease; Cyclooxygenase I | 1985 |
35 other studies available for dipyridamole and Arrhythmias, Cardiac
Article | Year |
---|---|
Blunted heart rate response as a predictor of cardiac death in patients undergoing vasodilator stress technetium-99m sestamibi gated SPECT myocardial perfusion imaging.
Topics: Aged; Arrhythmias, Cardiac; Connecticut; Death, Sudden, Cardiac; Dipyridamole; Electrocardiography; | 2010 |
Safety and feasibility of dobutamine and dipyridamole stress echocardiography in hypertensive patients.
Topics: Aged; Arrhythmias, Cardiac; Dipyridamole; Echocardiography, Stress; Equipment Safety; Feasibility St | 2002 |
Effects of acute myocardial ischemia on QT dispersion by dipyridamole stress echocardiography.
Topics: Aged; Arrhythmias, Cardiac; Dipyridamole; Echocardiography, Stress; Electrocardiography; Female; Hea | 2003 |
[ON AN INTERESTING ACTION OF PERSANTIN ON HEART CONDUCTION DISORDERS].
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Dipyridamole; Electrocard | 1964 |
EFFECTS OF 10-METHOXYDESERPIDINE ON THE ECG CHANGES INDUCED BY VASOPRESSIN IN UNANESTHETIZED RABBIT.
Topics: Animals; Arginine Vasopressin; Arrhythmias, Cardiac; Atropine; Bradycardia; Coronary Vessels; Dipyri | 1965 |
[Prevalence of dangerous arrhythmia during pharmacological stress echocardiography].
Topics: Arrhythmias, Cardiac; Atropine; Cardiotonic Agents; Dipyridamole; Dobutamine; Echocardiography, Stre | 2006 |
Stress testing in patients with implantable cardioverter-defibrillators: a preliminary report.
Topics: Adrenergic beta-Agonists; Aged; Arrhythmias, Cardiac; Blood Pressure; Cardiomyopathy, Dilated; Defib | 2007 |
[Complications of stress-echocardiography used for diagnosis of ischemic heart disease].
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiotonic Agents; Dipyridamole; Dobutamine; Echocardiography, S | 2008 |
Electroconvulsive therapy and electrocardiograph changes.
Topics: Aged; Arrhythmias, Cardiac; Depressive Disorder; Dipyridamole; Electrocardiography; Electroconvulsiv | 2008 |
[How dangerous is the dipyridamole test?].
Topics: Adult; Aged; Aminophylline; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Cardiac Complexes | 1983 |
Ventricular dysrhythmias following intravenous dipyridamole during "stress" myocardial imaging.
Topics: Arrhythmias, Cardiac; Dipyridamole; Heart; Heart Ventricles; Humans; Male; Middle Aged; Radionuclide | 1983 |
[Problems of the operated patient and suggestions for their treatment].
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Anticoagulants; Anxiety Disorders; Arrhythmias, Cardiac; As | 1982 |
Dipyridamole echocardiography for diagnosis of coexistent coronary artery disease in hypertrophic cardiomyopathy. Echo-Persantine International Cooperative (EPIC) Study Group--Subproject Hypertrophic Cardiomyopathy.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Coronary Angiograp | 1995 |
Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery disease.
Topics: Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Coronary Angiography; Coronary Disease; Coronary | 1993 |
[Utility of SPECT with 99m Tc-tetrofosmin and stimulus with dipyridamole in patients with permanent ventricular pacemakers].
Topics: Aged; Aged, 80 and over; Angina Pectoris; Arrhythmias, Cardiac; Cardiac Catheterization; Comorbidity | 2001 |
[Dipyridamole test as screening method in coronary disease].
Topics: Adolescent; Adult; Aged; Aminophylline; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Coron | 1977 |
[Experience with combined use of neurolepsy and vasodilator substances in the treatment of patients with acute myocardial infarct].
Topics: Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Dipyridamole; Drop | 1976 |
[Clinical and experimental results of treatment with amiodarone in coronary insufficiency].
Topics: Aged; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; Dipyridamole | 1975 |
Arrhythmias during dipyridamole test. Report of 3 cases.
Topics: Arrhythmias, Cardiac; Coronary Disease; Dipyridamole; Echocardiography; Electrocardiography; Humans; | 1992 |
Increased prevalence of ventricular arrhythmias in essential hypertensives with dipyridamole-induced ischemic-like S-T segment changes.
Topics: Arrhythmias, Cardiac; Coronary Angiography; Coronary Disease; Dipyridamole; Echocardiography; Electr | 1991 |
Dipyridamole-thallium tests are predictive of severe cardiac arrhythmias in patients with left ventricular hypertrophy.
Topics: Adolescent; Aged; Arrhythmias, Cardiac; Cardiomegaly; Dipyridamole; Female; Humans; Middle Aged; Pre | 1991 |
Relation between the incidence of arrhythmias and ischemic ST-segment depression during dipyridamole electrocardiography test in patients with coronary artery disease.
Topics: Adult; Aged; Arrhythmias, Cardiac; Coronary Disease; Dipyridamole; Electrocardiography; Female; Huma | 1991 |
Using body surface mapping to detect vulnerability to ventricular arrhythmias in patients with coronary artery disease.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Coronary Disease; Dipyridamole; Ele | 1987 |
Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery.
Topics: Age Factors; Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Diabetes Complications; | 1989 |
[Reverse redistribution in dipyridamole-loading thallium-201 images using single photon emission computed tomography].
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Diabetes Mellitus; Dipyridamole; Electrocardio | 1986 |
[The dipyridamole test in the 3d week after acute myocardial infarct].
Topics: Adult; Aged; Arrhythmias, Cardiac; Coronary Circulation; Dipyridamole; Electrocardiography; Exercise | 1987 |
Prevention of cardiac complications in peripheral vascular surgery.
Topics: Angiography; Arrhythmias, Cardiac; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Electr | 1986 |
Use of experimental myocardial infarct to demonstrate arrhythmogenic activity of drugs.
Topics: Animals; Arrhythmias, Cardiac; Dipyridamole; Dogs; Electrocardiography; Female; Heart Rate; Male; My | 1985 |
Dysgeusia after high dose dipyridamole treatment (short communication).
Topics: Aged; Arrhythmias, Cardiac; Dipyridamole; Dysgeusia; Humans; Male; Taste Disorders | 1985 |
Treatment of haemodynamic and electrocardiographic side-effects resulting from imipramine toxicity in rats and dogs.
Topics: Animals; Arrhythmias, Cardiac; Chromonar; Coumarins; Dipyridamole; Dogs; Electrocardiography; Female | 1985 |
[Effect of some sympathomimetic amines on the coronary resistance in the dog heart in situ during heart beat and asystole].
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Arteries; Blood Pressure; Bronchodilator | 1970 |
Differences among dipyridamole, carbochromen and lidoflazine in responses of the coronary and the renal arteries.
Topics: Acetamides; Adenosine; Animals; Arrhythmias, Cardiac; Blood Pressure; Coronary Circulation; Coronary | 1972 |
[Studies on the modification of circulatory depressant effect of bradycardia-inducing drugs].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Circulation; Blood Pressure; Bradycardi | 1968 |
[On the anti-arrhythmia activity of a new adrenergic blocking agent].
Topics: Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Bradycardia; Digitalis Glycosides; Dipyridam | 1966 |
Potentiation of adenosine and the adenine nucleotides by dipyridamole.
Topics: Acetylcholine; Adenine Nucleotides; Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Azaguanin | 1966 |